Status:
RECRUITING
Comparison of Diagnostic Performances of 3D FLAIR, DIR and PSIR Sequences in Optic Neuritis
Lead Sponsor:
University Hospital, Strasbourg, France
Conditions:
Multiple Sclerosis
Demyelinating Diseases
Eligibility:
All Genders
18+ years
Brief Summary
Ultimately improve the care of patients suffering from multiple sclerosis (1st cause of acquired non-traumatic disability in adults) and NMO spectrum diseases by using more efficient MRI sequences tha...
Eligibility Criteria
Inclusion
- Major subject (≥18 years old)
- Subject suffering from multiple sclerosis or an NMO spectrum disease
- Subject having received an MRI including 3D FLAIR, 3D DIR and 3D PSIR sequences
- Brain MRIs of eligible subjects acquired between April 1, 2019 and November 30, 2021.
- No opposition to the reuse of its data for scientific research purposes.
Exclusion
- Presence of opposition from the subject (and/or their legal representative if applicable) to the reuse of their data for scientific research purposes.
- Artifacts not allowing satisfactory interpretation
Key Trial Info
Start Date :
January 19 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 19 2025
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT06494228
Start Date
January 19 2024
End Date
January 19 2025
Last Update
July 10 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Service de Radiologie II, CHU de Strasbourg
Strasbourg, Les Hôpitaux Universitaires de Strasbourg, France, 67091